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Leukemia is a complex disease, which only became better understood during the last decades following the
development of new laboratory techniques and diagnostic methods. Despite our improved understanding of the
physiology of the disease, little is yet known about the causes of leukemia. A variety of potential risk factors have
been suggested so far, including personal habits and lifestyle, and a wide range of occupational or environmental
exposures. A causal association with leukemia has only been documented to date for ionizing radiation, benzene
and treatment with cytostatic drugs, but there is an ongoing scientific debate on the possible association of
leukemia with a number of other work-related hazards. In this article, we have reviewed scientific studies, published
over the past 5 years, which investigated potential associations between leukemia and exposure to occupational
risk factors. The systematic literature review took place via electronic databases, using specific search criteria, and
independent reviewers have further filtered the search results to identify the number of articles, presented in our
paper. A large number of studies included in the review referred to the effects of ionizing radiation, where new
data suggest that the effects of exposure to small doses of ionizing radiation should probably be reevaluated. Some
other works appear to substantiate a potential association of the disease with certain pesticides. Further research is
also suggested regarding the role of infectious agents or exposure to certain chemicals like formaldehyde or
butadiene in the pathogenesis of leukemia.
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Introduction
The term "leukemia" refers to a group of diseases with
different biological background, clinical presentation,
prognosis and response to treatment, characterized by a
malignant transformation of hematopoietic cells which
produce an abnormal leukemic population (clone) of cells
suppressing the production of normal blood cellular com-
ponents. The disease was first identified in the mid-19th
century when different researchers described a common
pathology caused by abnormalities of the white blood cells
[1], hence the term “Leukemia” which originates from the
Greek words “Leuko” (white) and “Haema” (blood). While
scientific research has advanced significantly since then as
regards to the underlying pathophysiology of the various
types of the disease, our knowledge on the causative
factors involved in the development of leukemia is
still limited.* Correspondence: drjpoly@gmail.com
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distribution, and reproduction in any mediumDifferent researchers have proposed a number of po-
tential risk factors for leukemia, but to date exposure to
ionizing radiation, alkylating agents and benzene [2] re-
main the only hazards for which an association with
leukemia has been substantiated.
An association between ionizing radiation and leukemia
was first assumed in the early 20th century, following the
effects of uncontrolled exposure of patients and medical
personnel to the radiation used for diagnostic and thera-
peutic purposes [1,3]. Those observations were further
corroborated by the findings of Life Span Study (LSS)
among the A-Bomb survivors of Hiroshima and Nagasaki
[4-7], which persist for decades following exposure to radi-
ation [8,9] and the follow-up studies among cleaning-
workers in Chernobyl reactor site [10].
Benzene is according to the current scientific knowledge
the second best-documented risk factor for the develop-
ment of leukemia [11]. Its chemical properties have led to
its widespread use as a solvent in a number of industrial
applications, and occupational exposure to benzene has
been documented for workers in different production sec-
tors i.e. production of chemicals, pharmaceuticals, plastics,entral Ltd. This is an Open Access article distributed under the terms of the
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Epidemiological studies have shown a significant associ-
ation between exposure to Benzene and the incidence of
acute myeloid leukemia (AML) [15-17].
Cytostatic drugs, and especially chemotherapeutic regi-
mens containing alkylating agents such as Busulfan,
Chlorambucil, Cyclophosphamide etc. used in the treat-
ment of solid organ malignancies are another documented
risk factor for developing leukemia, as a number of clinical
trials on cancer therapeutics has shown an association be-
tween this category of drugs and the development of sec-
ondary leukemia [18], particularly AML [19]. Despite their
known toxicity to oncology patients and the precautionary
measures taken to prevent occupational exposure, a num-
ber of workers from different disciplines could be exposed
to significant concentrations of cytostatic drugs during
their production, transportation, distribution, preparation
and administration to patients [20-22]. Nevertheless, little
is known regarding the potential effect of this exposure on
the risk of developing the disease [23-26].
Taking into account the limited knowledge on its ac-
tual causes, the investigation of the role of different
work-related risk factors in the development of leukemia
would be of great scientific interest, providing valuable
insight on the etiology of the disease and the available
options for the protection of health of specific categories
of workers or the public, given the widespread use of dif-
ferent chemical compounds and technological applica-
tions in common consumer products.
The growing number of related publications over the last
years indicates an increasing concern of the scientific com-
munity and recent studies have presented new information
as regards our cumulative experience from the application
of different technologies and chemical or biological factors
in industry, necessitating a review of the current literature
on the subject.
Therefore through this paper we systematically col-
lected and summarized all relevant scientific informa-
tion that has been published internationally in the
English language over the last years, exploring the
potential role of occupational "risk factors" in the devel-
opment of the disease.Materials and methods
The article review on the role of occupational risk factors
in the development of leukemia took place between
September and December 2010. The literature search was
carried out via the internet, using the online medical
database "Pubmed" supported by the US National Library
of Medicine and the more generic search-engine
"Google Scholar".
The methodology followed by the research team for the
selection of articles is presented schematically in Figure 1.At a first stage, all published articles containing the
word "leukemia” as part of their title, as a key-word or
as a reference in their full text have been collected.
A set of criteria was adopted to narrow down the
search results, excluding studies published more than
5 years prior to the review, studies that referred to sub-
jects younger than 18 years (since the review referred
to work-related risk factors) and studies whose full
text was not available in English. All types of publica-
tions (i.e. prospective or retrospective studies, original
articles, literature reviews, meta-analyses etc.) were
considered at this stage.
The initial search recovered more than 10.000 articles
(629 literature reviews) who were filtered by 2 different
reviewers as regards their pertinence to the scopes of the
study. The reviewers screened the abstracts of all col-
lected articles and considered for further review only
studies that referred to the potential effect of various
risk factors (exposures) in the development of leukemia.
The occupational or environmental nature of exposure
was not examined at this stage. The review investigated in-
formation on the potential role of occupational risk factors
regardless of the research type (toxicological, molecular,
epidemiological study etc.) therefore no selection took
place on the basis of specific study design. Nevertheless,
with the exception of a number of articles who were fur-
ther reviewed to elucidate potential points of interest, the
overwhelming majority of clinical trials and laboratory
studies were clearly non-relevant to the context of the re-
view and were directly excluded, limiting the number of
articles at the end of second phase to 278.
For the final selection process the remaining articles
were examined in detail by both reviewers. In cases of
agreement, the corresponding articles were either ex-
cluded or included in the final list, while in cases of ambi-
guity there was further discussion among the 2 reviewers
and a third reviewer who played the role of a referee, in
order to reach consensus.
Articles considered eligible for inclusion were those
that referred to specific categories of workers or expos-
ure to occupational hazards and their effect on leukemia.
The role of environmental exposures on leukemia was
beyond the scope of this paper and all related studies
were subsequently excluded.
A limited number of the reviewed articles on ionizing
radiation and benzene did not refer specifically to occu-
pational exposure, but their findings were considered
significant for understanding the role of those hazards
in occupational settings and were thus included in the
final list. Finally, while leukemia in children was beyond
the objectives of this study, the effect of parental occu-
pational exposure on the risk of the disease among their
offspring was considered work-related and therefore
similar studies were also included in the final review.
Figure 1 Article selection process for the review. The chart presented in this figure shows the overall process for the selection of articles from
the initial electronic search to the final selection of the reviewed studies.
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presented in Tables 1, 2 and 3 classified according to the
author, year, type of study and type of exposure. Table 1
presents the reviewed articles on physical hazards, Table 2
presents articles on chemical and biological hazards and




As anticipated, the largest proportion of studies referred
to ionizing radiation, which is to date the best docu-
mented risk factor for leukemia.
An update of Life Span Study findings has shown that
exposure to ionizing radiation at doses as low as those
usually recorded in occupational settings, leukemia inci-
dence follows a quadratic dose response pattern, which
peaks about 10 years following exposure and persists for
decades [6,9]. Moreover, there is uncertainty on whether
the proposed safety limits from the International Commis-
sion on Radiological Protection (ICRP) are appropriate,
since revised LSS data show that the risk of leukemia
remains increased even in groups with low cumulativeexposure to radiation while most of the existing studies do
not have sufficient statistical power to identify existing
associations at such low exposure levels [98,99].
Ongoing observations on the impact of Chernobyl acci-
dent have shown that predictions based on LSS data
present a high margin of error [100]. To date, a statistically
significant increase of leukemia incidence has only been
observed among the cleaning personnel that worked
around the reactor site after the accident [29,30]. The
study of Abramenko et al on specific genetic variants of
CLL among this group of workers [28] implies a potential
association among exposure to radiation and CLL which
warrants further investigation given the lack of supporting
evidence from previous studies.
As regards to a potential excess risk of leukemia
among workers in the nuclear industry, the results of
recent studies remain inconclusive. A number of studies
among workers in nuclear-weapon industry have pro-
duced negative results [32-37] and despite sporadic
positive findings, no significantly increased risk of
leukemia has been established to date for nuclear power
plant personnel [38,98,99] and other categories of
workers involved in other industrial applications of
Table 1 Reviewed articles on physical hazards and leukemia
Researcher Year Type of study Exposure Main findings
A. Ionizing radiation and leukemia
1) Update of LSS study findings
Little et al. [6] 2009 Review Ionizing radiation Leukemia RR follows the pattern of LSS study for low dose (occupational) exposure -
Lower RR per dose unit for higher doses of radiation
Richardson et al. [9] 2009 Cohort study Ionizing radiation Exposure to >5 mGy of radiation is responsible for 1/3 of leukemia cases after 5 decades –
ERR/Gy follows a quadratic dose-response model for AML. ALL and CML mortality follow
a linear dose-response model.
2) Cleanup workers employed in Chernobyl nuclear incident
Rahu et al. [27] 2006 Cohort study Ionizing radiation No significant increase in leukemia incidence among workers (SIR 1.53, 95% CI 0.62 - 3.17).
A marginally significant increase has been observed among Latvian workers but it was
based on a small number of cases.
Abramenko et al. [28] 2008 Cohort study Ionizing radiation Among a cohort of CLL patients, specific genetic polymorphisms where observed
more frequently among cleanup workers exposed to radiation following the
nuclear accident in Chernobyl than in non-exposed CLL patients
Romanenko et al. [29,30] 2008 Nested case-
control study
Ionizing radiation Positive linear trend (p = 0.03) between increasing exposure to radiation and leukemia risk.
The ERR/Gy for leukemia was 3.44 (95% CI 0.47 – 9.78). A linear dose - response relationship
has been shown for ALL and (surprisingly) for CLL.
Kesminiene et al. [31] 2008 Case-control study Ionizing radiation A statistically significant association was shown (at 90% but not at 95% level) between AL and
employment as a cleanup worker in the surrounding area (<30 km) of Chernobyl accident
site (OR 8.31, 90% CI 1.17 - 122).
3) Workers in nuclear industry
Boice et al. [32] 2006 Cohort study Ionizing radiation No significant increase in leukemia mortality (SMR 1.21, 95% CI 0.69- 1.97) or increased leukemia
risk for the highly-exposed group (RR 1.34, 95% CI 0.73–2.45) was shown among workers.
Richardson et al. [33] 2007 Cohort study Ionizing radiation
(& exposure to chemicals)
A borderline significant increase of leukemia mortality was shown (at 90% but not at
95% level) only for operators and manual workers (SMR 1.36, 90% CI 1.02 - 1.78) and
for workers employed >30 years (SMR 1.63, 90% CI 1.07 - 2.52).
Richardson et al. [34] 2007 Nested case-
control study
Ionizing radiation Assuming a 3-year time lag, no significantly increased ERR/10 mSv was shown for all leukemias
(0.041, 90% CI -0.001 – 0.116), for leukemias excluding CLL (0.077, 90% CI 0.014 – 0.198)
or for myeloid leukemia (0.123, 90% CI 0.021 - 0.354).
Schubauer-Berigan et al. [35] 2007 Nested case-
control study
Ionizing radiation A non-significant positive association between radiation dose and leukemia risk was shown
for doses 10 - 100 mSv, with an estimated ERR/10 mSv of 0.068 (95% CI -0.029 - 0.24).
Schubauer-Berigan et al. [36] 2007 Nested case-
control study
Ionizing radiation A non-significant positive association between radiation dose and CLL risk was shown for
doses 10 - 100 mSv, with an estimated ERR/10 mSv of 0.20 (95% CI -0.035 – 0.96).
Matanoski et al. [37] 2008 Cohort study Ionizing radiation No statistically significant increase of leukemia mortality (SMR 0.91, 95% CI 0.56 – 1.39
and 0.42, 95% 0.11 – 1.07 for exposure to > 5.0 mSv and <5.0 mSv of radiation respectively)
was shown among workers
Ashmore et al. [38] 2010 Review Ionizing radiation Previous study of IARC (2005) who found no statistically significant association between
leukemia and radiation exposure among workers in nuclear industry could be biased




















Table 1 Reviewed articles on physical hazards and leukemia (Continued)
4) Medical applications of radiation
Lie et al. [39] 2008 Cohort study Ionizing radiation No significant increase in leukemia risk was found for the group nurses with the
longest (> 30 years) employment in posts exposed to radiation compared to the
group of non-exposed nurses (RR 0.77, 95% CI 0.35 – 1.69).
Samerdokiene et al. [40] 2009 Cohort study Ionizing radiation No significant increase in leukemia incidence (SIR 3.3, 95% CI 0.68- 9.63 for men and
2.67, 95% CI 0.92-4.2 for women) was shown among personnel employed in medical
applications of ionizing radiation.
Ramos et al. [41] 2008 Case-control study
(exposure assessment)
Ionizing radiation The projected risk of leukemia cases/1000 person-years based on cumulative radiation exposure
among a group of interventional radiologists differed between 2 methods of exposure assessment
(1.07-3.98 according to the physical method compared to 1.07-11.21 for the biological method)
suggesting a potential improper use of personal dosimeters.
Ramos et al. [42] 2009 Molecular
epidemiological study
Ionizing radiation The projected LAR of leukemia (cases/1000 person-years) among interventional radiologists
due to radiation exposure, was much higher according to biological methods of exposure
assessment (9.2) compared to physical methods (2.18).
5) Industrial applications of ionizing radiation
Ahn et al. [43] 2008 Cohort study Ionizing radiation
(industrial applications)
No statistically significant increase of leukemia SMR or SRR was shown among personnel
exposed to radiation (workers in medical applications, research laboratories, nuclear
facilities, non-destructive testing, military facilities etc.).
6) Extraction and use of uranium compounds
Storm [44] 2006 Cohort study Depleted uranium No statistically significant increase of leukemia incidence was found among military personnel
exposed to depleted uranium used during military operations (SIR 1.4, 95% CI 0.4 - 3.5).
Mohner [45] 2006 Case-control study Uranium mining
(radionuclides)
No significant increase of leukemia risk was found in the group with the highest cumulative
exposure to radon (> 400 mSv) compared to the low exposure group (OR 2.21, 90% CI 1.25–3.91).
Mohner [46] 2010 Case-control study Uranium mining
(radionuclides)
No significant increase of leukemia risk was found among the group of workers
with the highest (> 200 mSv) cumulative exposure (OR 1.33, 90% CI 0.82-2.14).
B. Non-ionizing radiation (EMF) and leukemia
Roosli [47] 2007 Cohort-study ELF EMF A significantly increased Hazard Ratio was shown for myeloid leukemia among the
workers with the highest exposure to ELF EMF (HR 4.74, 95% CI 1.04-21.6, p=0.035).
Kheifets [48] 2008 Meta-analysis EMF A small but statistically significant increase in leukemia risk was found among the




















Table 2 Reviewed articles on chemical and biological hazards and leukemia
Researcher Year Type of study Exposure Main findings
1) Exposure to benzene
Zhang [49] 2007 Molecular
epidemiological study
Exposure to benzene A statistically significant increase % of genetic aberrations commonly observed in
chemotherapy-related leukemias has been shown among workers exposed to
benzene compared to non-exposed controls.
Richardson [50] 2009 Cohort study Exposure to benzene The observed pattern of leukemia mortality among rubber-production workers exposed to
benzene, compared to the prediction of a TSCE statistical model suggests that benzene
plays a role to the kinetics of cancer cells rather than the initial malignant transformation.
Rushton [51] 2010 Ecological study Exposure to benzene The Attributable Fraction (AF) of population mortality from acute non-lymphocytic
leukemia related to occupational exposure to benzene was estimated at
0.25% (95% CI 0.0-4.65).
2) Exposure to organic solvents (incl. benzene)
Costantini et al. [52] 2008 Polycentric case-
control study
Organic solvents A significant increase of CLL risk has been shown among the groups of workers with
moderate – high exposure to Benzene (OR 1.8, 95% CI 0.9-3.9), and high exposure
to Xylene (OR 1.9, 95% CI 0.8-4.5) and Toluene (OR 2.1, 95% CI 0.9-4.7).
Cocco et al. [53] 2010 Case-control study Organic solvents A small but statistically significant increase of CLL risk (OR 1.3, 95% CI 1.1-1.6) was
shown for workers ever exposed to organic solvents (exposure to any solvent or
combined exposure of benzene with toluene, xylene or gasoline) compared to non-exposed.
Lehman et al. [54] 2006 Cohort study Organic solvents No statistically significant increase in mortality from leukemia was found among
exposed workers in footwear industry, compared with the general population
(SMR 1.01, 95% CI 0.67-1.48).
3) Exposure to Dioxins
Atallah et al. [55] 2007 Case-report Dioxins – Agent Orange A rare case of Acute Promyelocytic Leukemia (APL) in a former USAF pilot, who
was involved in spraying Agent Orange during the Vietnam War, was reported.
Collins et al. [56] 2009 Cohort-study TCDD No significant increase of leukemia mortality was shown among exposed workers
(SMR 1.9, 95% CI 1.0- 3.2). No significant association was shown between leukemia
mortality and cumulative exposure (ppb) to TCDD (p=0.34).
4) Exposure to chemical compounds used in the synthetic rubber industry
Delzell et al. [57] 2006 Cohort-study BD, DMDTC and Styrene A positive association was shown between (all) leukemias, CML and CLL mortality and
occupational exposure to BD. A positive association was also found between leukemia
and exposure to Styrene or DMDTC, but in both cases there was also co-exposure to BD.
Beall et al. [58] 2007 Cohort-study Solvents, aromatic amines No increased leukemia incidence (SIR 0.68, 95% CI 0.14-1.98) or mortality (SMR 0.95,
95% CI 0.31- 2.23) has been observed among exposed workers, compared to
the general population.
Cheng et al. [59] 2007 Cohort-study BD A statistically significant association was shown between leukemia risk and exposure
to BD, for cumulative exposure in ppm-years (RR 3.84, 95% CI 1.51- 9. 76), frequency
of exposure (RR 4.26, 95% CI 1.62-11.21) and average exposure in ppm (RR 3.93,
95% CI 1.5-10.32).
Sathiakumar et al. [60,61] 2009 Cohort-study BD and Styrene In contrast to the results observed among men workers, no statistically significant
association was found between exposure of women workers to BD and mortality




















Table 2 Reviewed articles on chemical and biological hazards and leukemia (Continued)
5) Exposure to Formaldehyde
Beane Freeman [62] 2009 Cohort-study Formaldehyde A non-significant increase in mortality from (all) leukemias (RR 1.42, 95% CI 0.92- 2.18)
and myeloid leukemia (RR 1.78, 95% 0.87- 3.64) was shown in the group with the
highest exposure (> 4ppm) compared to the group with the lowest exposure.
Hauptmann [63] 2009 Case-control study Formaldehyde A statistically significant association between mortality from myeloid leukemia and
increasing years of employment (p=0.02) or maximum exposure to formaldehyde
(p=0.036) was shown among embalmers.
Zhang [64] 2010 Molecular
epidemiological study
Formaldehyde A statistically significant decrease of cell-lines, reduced activity of the CFU-GMs and
increase of leukemia-related genetic aberrations has been shown among workers
exposed to formaldehyde compared to non-exposed controls.
Speit [65] 2010 Letter to the editor Formaldehyde A number of methodological issues call into question the reliability of the findings
of the study of Zhang et al, on in-vitro evidence of leukemia-specific chromosomal
changes in workers exposed to formaldehyde.
6) Exposure to Lead
Lam [66] 2007 Cohort study Occupational
exposure to lead
A non-significant increase of CML incidence was shown (SIR 1.75, 95% CI 0.02- 9.71)
among the cohort of workers exposed to lead (metal constructions, metal processing
industry, foundries, manufacture of batteries and electronics, glass production).
7) Exposure to different types of pesticides, herbicides and insecticides
Mahajan [67] 2006 Cohort study - (AHS) Organophosphate
pesticide - Fonofos
A statistically significant increase of leukemia risk was found among pesticide applicators
with the highest exposure (based on duration and intensity of exposure) compared to the
non-exposed (RR 2.67, 95% CI 1.06-6.70).
Mahajan [68] 2006 Cohort study - (AHS) Organophosphate
pesticide - Phorate
The small number of recorded cases of leukemia among exposed workers did not
allow for any reliable conclusions.
Miligi [69] 2006 Case-control study Different groups of
pesticides
No significant association with leukemia risk was shown for exposure to fungicides
(OR 1.0, 95% CI 0.7 -1.3), herbicides (OR 1.4, 95% CI 0.8-2.3), insecticides (OR 1.0, 95% CI
0.7 -1.4), molluscicides (OR 0.9, 95% CI 0.3-2.5) or rodenticides (OR 0.4, 95% CI 0.1-1.2).
Hansen [70] 2007 Cohort study Arsenate pesticides, Atrazine,
Dichlorvos, Captafol, Amitrol,
Lindane, DDT
A significant increase of leukemia incidence (SIR 2.33, 95% CI 1.32- 4.10) was found among
the group of gardeners with high exposure to pesticides, previous to the 1960 restriction
of the use of potentially carcinogenic substances.
Purdue [71] 2007 Cohort study - (AHS) Organochlorine insecticides
(Aldrin, Chlordane, DDT, Dieldrin,
Heptachlor, Lindane, Toxaphene)
A marginal statistically significant association was found between the leukemia risk and
previous use of any of the Organochlorine pesticides (RR 2.0, 95% CI 1.0-4.1), Lindane
(RR 2.0, 95% CI 1.1-3.5) or Heptachlor (RR 2.1, 95% CI 1.1-3.9).
van Bemmel [72] 2008 Cohort study - (AHS) Thio-carbamate herbicide EPTC No statistically significant increase of leukemia risk was shown for workers exposed
EPTC (RR 1.31, 95% CI 0.75-2.28) compared to the non-exposed.
Chrisman Jde [73] 2009 Ecological study All pesticides A statistically significant increase of leukemia mortality was observed in areas with increased
per capita use of pesticides (MRR 1.6, 95% CI 1.55-1.66 and 1.93, 95% CI 1.87-2.0 for the
1st quartile of pesticide use, compared to the 2nd and 3rd quartile respectively).
Delancey [74] 2009 Cohort study - (AHS) Herbicide Metribuzin A statistically non-significant increase of leukemia risk was shown among the group of
pesticide applicators with the highest cumulative exposure to Metribuzin




















Table 2 Reviewed articles on chemical and biological hazards and leukemia (Continued)
Orsi [75] 2009 Case-control study Organochlorine insecticides,
Phenoxy – herbicides, Triazine-
containing herbicides
A significant association was shown between the risk of hairy cell leukemia (HCL)
and exposure to Organochlorine insecticides (OR 4.9, 95% CI 1.1-21.2), Phenoxy-herbicides
(OR 4.1, 95% CI 1.1-15.5) and Triazine-containing herbicides (OR 5.1, 95% CI 1.4-19.3).
Rusiecki [76] 2009 Cohort study - (AHS) Exposure to Permethrin No significant association was shown between exposure to Permethrin and leukemia risk
among workers (RR 1.74, 95% CI 0.83 - 3.64 and 1.34, 95% CI 0.61-2.92 for workers with the
longest duration of exposure or the highest cumulative exposure respectively).
8) Combined chemical and biological hazards in agriculture
Bassil [77] 2007 Literature review Combined exposure to pesticides,
insecticides and work with livestock
6 cohort studies and 8 case-control studies have shown a statistically significant
association between pesticide exposure and leukemia risk, and 2 cohort studies
have shown an association between leukemia risk and work with livestock.
9) Biological hazards in agriculture and food industry
Moore [78] 2007 Case-control study (multicentric) Occupational exposure
to meat products
A statistically significant association was found between CLL risk and occupational exposure
to meat products, for workers with exposure> 16 years to cattle and poultry meat
(OR 2.51, 95% CI 1.12 - 5.66 and 2.06, 95% CI 1.17 - 3.63 respectively).
Johnson [79] 2010 Cohort study Occupational exposure
to meat products
A statistically significant increase of lymphatic leukemia mortality was shown among men
workers in slaughterhouses and poultry meat processing plants (SMR 5.9, 95% CI
1.6-15.2). No similar increase was found among female workers.
Johnson [80] 2010 Cohort study Occupational exposure
to meat products
A statistically significant increase of lymphatic leukemia proportional mortality was
observed only among non-white women workers in slaughterhouses and poultry
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destructive testing etc.) [39,40,43].
Exposure to minimal doses of radiation during the min-
ing and processing of uranium has not been associated with
a significantly increased risk of leukemia among exposed
workers [45,46]. Moreover, despite existing weaknesses in
their methodological design and statistical power [101],
recent studies did not record any statistically significant
increase in leukemia risk among military personnel
exposed to depleted uranium products during military
operations [44,102].
Non-ionizing radiation (EMF)
Occupational exposure to electromagnetic fields (EMF)
constitutes an area of ongoing scientific debate over the re-
cent years, mainly because of the rising public health con-
cern regarding EMF. There has been high inconsistency
among the results of previous studies, but the research
group of the International Commission on Non-Ionizing
Radiation Protection (ICNIRP) concluded that existing lit-
erature on EMF exposure converges on the existence of a
small but statistically significant increase in leukemia risk
among occupationally exposed groups [47]. These findings
were further supported by more recent studies, which iden-
tified a small but statistically significant excess risk of
leukemia among workers highly exposed to extremely low
frequency electromagnetic fields (ELF EMF) [47,48].
Benzene
Among various chemical exposures in the workplace,
Benzene is a well-documented risk factor for leukemia.
As regards the potential toxicity of Benzene at cellular
level, Zhang et al have observed in vitro a significantly
higher number of genetic lesions associated with
chemotherapy-related leukemia among Benzene-exposed
workers [49], while Richardson et al have proposed a
model of two-stage clonal expansion (TSCE) of cancer
cells where Benzene acts as a promoter (rather than an
initiator) affecting the kinetics of initiated blood cells
[50]. A recent study in Great Britain estimated that
due to the widespread use of benzene-containing com-
pounds in various applications, occupational exposure to
Benzene is responsible for about 0.19% of the overall in-
cidence of non-lymphocytic leukemia in men and 0.34%
in women [51], while a similar study in Korea has shown
that Benzene constitutes at population-level a more sig-
nificant occupational risk factor for leukemia than ioniz-
ing radiation [103].
Other organic solvents
Most epidemiological studies on occupational exposure to
organic solvents other from Benzene have not investigated
exposure to each compound separately, therefore the
effect of co-exposure to benzene in the observed excessrisk of leukemia could not be ruled out [52,53]. In a single
study where exposure to organic solvents (Toluene,
Hexane, Acetone, and Methyl-ethyl-ketone) was investi-
gated independently from Benzene, no significantly in-
creased risk of leukemia has been observed among the
exposed workers [54].
Butadiene and dimethyl-dithio-carbamate
An interesting finding that warrants further research
has occurred from a series of studies conducted on
workers in the synthetic rubber industry, where a statis-
tically significant excess risk of CML and CLL following
a dose-response relationship was shown among workers
exposed to 1.3-butadiene (BD) and dimethyl-dithio-car-
bamate (DMDTC) [57,59]. Interestingly, a similar find-
ing was not observed among female workers, although
their cumulative exposure to the specific compounds
had been much smaller than men [60,61].
Formaldehyde
Although formaldehyde has been classified by the Inter-
national Agency for Research on Cancer (IARC) in Group
1 “Carcinogenic to Humans” as regards to other types of
malignancies [104,105], a potential role in the develop-
ment of leukemia remains an area of ongoing scientific
controversy, as epidemiological findings remain inconclu-
sive [62,106] and no plausible theory has been proposed to
date to explain a toxic effect on progenitors of blood cells
[107]. In 2 recent Meta-analyzes of relevant studies how-
ever, a statistically significant excess risk of leukemia has
been observed among those occupationally exposed to for-
maldehyde [108,109], while despite the criticism over its
methodological weaknesses [110] an additional study has
shown a statistically significant dose–response association
between exposure to formaldehyde and mortality from
myeloid leukemia among embalmers [63]. As regards the
elucidation of the potential role of formaldehyde in the
pathogenesis of leukemia, Zhang et al have reported
in vitro evidence of formaldehyde myelotoxicity and iden-
tification of leukemia-characteristic genetic lesions among
the myeloid lineage of formaldehyde-exposed workers
[64], although there have been major objections to their
findings by a different group of researchers [65]. Overall,
while existing data could provide some explanation for the
potential toxicity of Formaldehyde in remote target-organs
and the negative findings in experimental animals, it
seems that there is still a long way when it comes to docu-
ment a role of Formaldehyde in the pathogenesis of
leukemia [111].
Lead
The toxic effects of exposure to Lead on bone marrow
have long been recognized. However, the cohort study of
Lam et al. among lead-exposed workers (metal
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http://www.occup-med.com/content/8/1/14construction, metal processing, battery manufacture, glass
production and electronics’ industry) has not detected any
significant increase of leukemia risk [66].
Pesticides
Pesticides are a class of chemicals long suspected for
carcinogenicity, and a number of different studies have
been conducted over the last decade to investigate the
toxic effect of specific classes of pesticides or compounds
and their potential role in the development of leukemia.
With the exception of an Italian case-control study which
has shown no significant association between leukemia
risk and exposure to the main categories of pesticides [69],
a number of studies have recorded statistically significant
excess risk of leukemia among agricultural workers
exposed to pesticides in general [73,77], or specific
categories of pesticides such as Phenoxy-herbicides,
Triazine herbicides, Arsenic-containing pesticides, Atra-
zine, Lindane, Dichloro Diphenyl Trichloroethane
(DDT), etc. [70,75]. A positive association was also
shown between leukemia and exposure to organophos-
phate pesticide Fonofos [67], while for workers exposed
to thio-carbamate herbicide EPTC [72], Organochlorine
insecticides [71], Metribuzin [74] and Permethrin [76]
no statistically significant excess leukemia risk was
found.
Infectious agents – contact with animals
The potential association of leukemia with exposure to
infectious agents is not a new theory but there seems to
be a renewed interest as regards to the epidemiological
investigation of this hypothesis during the last decade. A
number of epidemiological studies have investigated the
existing risk of leukemia among specific occupational
groups in livestock farming, food production and pro-
cessing where a higher theoretical risk of exposure to
biological agents from the animal population exists
[112-114]. The findings of those studies support the
above hypothesis, as a statistically significant increase of
leukemia risk was shown for workers in livestock farm-
ing [77,115], and a number of occupations i.e. workers
in slaughterhouses, butchers, cooks, etc. involved in the
processing of animal meat products [78-80].
Specific occupational groups at risk
Of the published epidemiological studies that investigated
potential associations of leukemia with specific occupa-
tional groups over the last 5 years, a statistically significant
increase in mortality from leukemia has been recorded
among the personnel of chemical laboratories [84] and
oil processing facilities [86], while no increased risk for
leukemia was shown for firefighters [85] and tannery
workers [88]. In 2 epidemiological studies conducted
among healthcare personnel, no increased risk forleukemia was shown for the group of nurses [81] and neu-
rosurgeons [83] while the findings of a third study which
has shown increased mortality from CLL among nurses
may be strongly affected by overdiagnosis of the disease
due to the increased health awareness of the specific group
[82]. Furthermore, a number of ecological-design studies
have recorded a statistically significant excess risk of
leukemia among specific categories of workers which in-
clude women (other than nurses) working in the
healthcare sector [89], workers whose tasks involve expos-
ure to Polychlorinated Biphenyls (PCBs) and printing inks
[91], workers exposed to benzene or pesticides or working
near high voltage lines [92], workers in plastic production,
cleaning and construction work [93], and several categor-
ies of workers in the agricultural sector i.e. fruit and vege-
table growers, nursery workers, farmers, florists etc. [93].
Parental occupational exposure and childhood leukemia
With regards to the potential association of childhood
leukemia with parental occupational exposure, paternal
exposure to pesticides and herbicides has not been associ-
ated with increased risk [94]. The study of Pearce et al has
shown a potential association of paternal exposure to
EMF with childhood leukemia, but their findings could be
the effect of co-exposure to ionizing radiation [95]. Finally,
paternal exposure to carcinogens [97] and maternal expos-
ure to solvents [96] especially during pregnancy and after
birth have been associated with increased risk of child-
hood leukemia among their offspring.
Conclusions
The studies included in this literature review, present
the current scientific knowledge on the potential effect
of work-related hazards in the pathogenesis of leukemia.
It must be noted, a number of those studies suffer from
methodological weaknesses which in certain cases con-
stitute their findings precarious.
Given the relatively low incidence and the long natural
history of the disease, the investigation of a potential effect
of an occupational exposure on leukemia requires large-
scale cohort studies with long follow-up period to acquire
the necessary statistical strength, which usually exceeds
the resources or the size of the study cohort. Even when
the above conditions are met, the statistical strength of a
study can be significantly reduced if the study protocol for
the assessment of exposure contains flaws. The establish-
ment of the role of an occupational hazard in the develop-
ment of leukemia assumes the demonstration of both a
statistically significant impact on leukemia incidence or
mortality between the exposed and non-exposed as well as
a dose-response effect for different levels of exposure. In
cases where available data on personal exposure is insuffi-
cient, as appears to be the case for a number of the cohort
studies included in this review, an over- or under-
Table 3 Reviewed articles on other hazards and leukemia
Researcher Year Type of study Exposure Main findings
A) Occupational exposure and risk of leukemia among different categories of workers
1) Healthcare workers
Dimich-Ward [81] 2007 Cohort study Working as a nurse No increased leukemia mortality (SMR 0.78, 95% C .49-1.18) or incidence was found among the
cohort of nurses (SIR for myelogenous and lympha c leukemia was 1.21, 95% CI 0.85- 1.68
and 1.02, 95% CI 0.63-1.56 respectively).
Abel [82] 2009 Cohort study
(Nurses’ Health Study)
Working as a nurse A statistically significant increase of CLL incidence as found among nurses
compared to the general population (SIR 1.35, 95% I 1.17-1.54).
Lollis [83] 2010 Cohort study Exposure to different health
hazards of operating theaters
No statistically significant increase in mortality from eukemia was observed
among neurosurgeons compared to the general p ulation (SMR 1.2, 95% CI 0.75-1.9).
2) Workers in chemical laboratories
Kubale [84] 2008 Cohort study Radionuclides, benzene and other hazards in
the laboratories of nuclear research facilities
Leukemia mortality of workers did not differ signif ntly from the general population
(SMR 0.78, 95% CI 0.45-1.25). A significant positive sociation was shown between
leukemia risk and duration of employment for tho employed >20 years (SRR was
9.51, 95% CI 1.67-54.17 and 11.44, 95% CI 1.88-69.5 for an estimated 2- or 5-year
time-lag of the disease respectively).
3) Firefighters
Bates [85] 2007 Case-control study Inhalation of toxic combustion products The risk of developing leukemia did not differ sign cantly between firefighters and the
non-exposed group (OR 1.22, 95% CI 0.99-1.49).
4) Workers in petroleum processing facilities
Huebner [86] 2009 Cohort study Byproducts of petroleum distillation
and processing
A statistically significant increase of mortality from ute (non-lymphoblastic) leukemia
was observed among workers in the chemical dep tment (SMR 1.81, 95% CI 1.06-2.90),
but no association with duration of employment o specific job posts was identified.
Gazdek [87] 2007 Ecological study Emissions from oil and gas
processing plants
Statistically significant geographic variation of acut myeloid leukemia incidence was
observed among populations of different regions, pending on their proximity
to oil- and gas-processing plants.
5) Tannery workers
Iaia [88] 2006 Cohort study Chemicals used in leather processing No significant increase of myeloid leukemia morta was found among tannery workers
exposed to chemicals used for leather processing R was 2.08, 90% CI 0.82–4.37
for men and 5.99, 90% CI 1.06-18.87 for women).
6) Different occupational categories
Firth [89] 2007 Ecological study Different occupational exposures
of women
A significant increase of leukemia proportional mo lity was found among
women employed in the healthcare sector (PMR 1 2, 95% CI 1.08- 2.09) but not
for nurses (PMR 1.42, 95% CI 0.96-2.01).
Hoffmann [90] 2008 Case-control study Ionizing radiation, pesticides and EMF 15% of men (16% of women) participants reported ccupational exposure to pesticides,
4% (8% women) reported exposure to ionizing rad tion (for > 1 year) and 64% of participants
reported having lived sometime in their life in the roximity (<20 km) of a nuclear plant.
Richardson [91] 2008 Case-control study Different occupational exposures A statistically significant increase of CLL risk was sho among workers exposed to













































Table 3 Reviewed articles on other hazards and leukemia (Continued)
Kaufman [92] 2009 Case-control study Benzene, pesticides, ionizing
radiation and EMF
A statistically significant increase of myeloid leukemia was shown among workers exposed
to Benzene (OR 3.9, 95% CI 1.3- 11), other non-specified solvents (OR 2.1, 95% CI 1.1- 4.9),
pesticides (OR 3.8, 95% CI 2.1-7.1) and EMF (OR 4.3, 95% CI 1.3-15).
McLean [93] 2009 Case-control study Different occupational exposures A statistically significant increase of leukemia risk was found among workers employed
in fruit and vegetable cultivation (OR 2.62, 95% CI 1.51 - 4.55) and in nurseries (OR 7.51,
95% CI 1.85-30.38), machine operators in plastic production facilities (OR 3.76, 95% CI 1.08-13.08),
tailors and dressmakers (OR for CLL 7.01, 95% CI 1.78-27.68), cleaners (OR for CLL 2.04, 95% CI
1.00-4.14) and construction workers (OR for CLL 4.03, 95% CI 1.30-12.53).
B) Occupational exposure and risk of leukemia among the offspring of different categories of workers
Pearce [94] 2006 Case-control study Pesticides and herbicides Paternal occupational exposure to pesticides and herbicides did not appear to be associated
with a higher risk of leukemia among their offspring (OR 0.55, 95% CI 0.26-1.16 and 1.15,
95% CI 0.61 - 2.17 for children living in urban and rural areas respectively).
Pearce [95] 2007 Case-control study EMF, ionizing radiation A statistically significant association was shown between the risk of childhood leukemia
and previous paternal occupational exposure to EMF (and ionizing radiation) (OR 1.31,
95% CI 1.02-1.69), especially among the offspring of electricians (OR 1.59, 95% CI 1.12 - 2.26).
McKinney [96] 2008 Case-control study Solvents, degreasing and
cleaning agents
A statistically significant association was found among acute lymphoblastic leukemia risk in children
and maternal exposure to solvents, degreasing and cleaning agents, during the period of pregnancy
(OR 2.7, 95% CI 1.6- 4.6) and postpartum (OR 1.9, 95% CI 1.1-3.3).
Perez-Saldivar [97] 2008 Case-control study Carcinogenic compounds A statistically significant association was found between childhood leukemia risk and previous paternal




















Polychronakis et al. Journal of Occupational Medicine and Toxicology 2013, 8:14 Page 13 of 16
http://www.occup-med.com/content/8/1/14estimation of exposure in certain groups of workers may
have led to non-differential misclassification, reducing
their statistical strength below the point where a weak
(but existing) statistical association could be identified.
Case-control studies were susceptible to even more types
of error, since apart from misclassification bias as regards
the exposure (or the diagnosis, especially in studies based
on historical records) major types of systematic error could
undermine the reliability of their findings. Most case-
control studies took place long after exposure, and the pos-
sibility of recall-bias, leading to an erroneous estimation of
exposure, is high. Recall-bias could introduce a major error
in the results of the studies especially when it is unevenly
distributed among cases and controls (e.g. studies where
exposure assessment was based on indirect information
given by close relatives of colleagues of leukemia patients).
Furthermore, some of the studies may have been affected
by selection bias either as a result of a change in the com-
position of their reference population (e.g. migration of
leukemia patients for diagnostic or therapeutic purposes
outside a country may have led to over-representation of
lower socio-economic classes and specific occupational
groups among cases) or the over-representation of protect-
ive health behaviors among controls due to the followed
sampling methodology.
A major concern with regards to published literature re-
views and meta-analyses was the low comparability among
the studies they were based on, as their different methodo-
logical design, analytical methods and presentation of re-
sults, made even simple comparisons among their findings
difficult, let alone further processing of the data for the
purpose of meta-analysis. This has affected some of the
findings presented in this review, as some of the meta-
analyses, as admitted by their own authors, could have
reached completely different results if some of the large-
scale studies which have been excluded from the analysis
had met the criteria for inclusion.
Overall, during the reference period of this study there
have not been any radical changes in the existing scien-
tific knowledge as regards the role of work-related haz-
ards in the pathogenesis of leukemia.
The findings of the reviewed articles confirm or fail to
negate previous scientific observations on the effect of
known risk factors, and there is adequate consistency
among researchers as to the causal association between
ionizing radiation or benzene and leukemia. Nevertheless,
the results of different studies remain contradictory as
regards the effect of radiation on different occupational
groups, and the impact on leukemia risk at different
exposure levels. Regarding exposure to benzene as a single
compound, or as part of mixtures of solvents, the findings
are consistent as to a positive association with the risk of
leukemia among exposed workers, yet no agreement exists
on its exact role on the development of the disease.The epidemiological findings of different studies remain
contradictory on the role of most of the remaining sug-
gested risk factors. The positive associations shown by a
number of studies as regards occupational exposure to
EMF, BD or infectious agents warrant further research in
the future, as different researchers fail to reproduce their
statistically significant results. In the case of formaldehyde
apart from the inconsistency of epidemiological findings
as regards the effect on leukemia among exposed workers,
there is also a scientific debate as to the plausibility of a
theoretical model of action explaining its role in the devel-
opment of the disease. Finally, the reviewed studies on oc-
cupational exposure to a number of plant protection
products (pesticides, herbicides, insecticides) indicate a
large heterogeneity among this group of chemical com-
pounds as regards their potential effect on the risk of
leukemia, and could provide an adequate explanation
for the low reproducibility of findings among different
researchers when characterization of exposure is not
clearly defined.
The number of collected articles (especially cohort
studies) investigating the potential association between
different occupational hazards and leukemia, published
during the previous years, indicates a growing scientific
interest in the specific field in an attempt to improve
our understanding on the causal factors of the disease.
Nevertheless, based on the reviewed studies the potential
effect of those hazards on the observed incidence and
mortality of leukemia, if existing, is expected to be so
subtle that could easily go unnoticed by small- or
medium-scale epidemiological studies. Therefore, even
negative results should be evaluated with caution, pend-
ing additional information from ongoing research.
Technology has provided new tools to researchers dur-
ing the last decades for in vitro investigation of diseases
like leukemia at cellular or molecular level. This will be
perhaps the key to unraveling the pathophysiological
mechanisms of this complex disease and acquire new
insight on the actual causes of leukemia in the future,
since epidemiology appears to have reached its limits as
regards to introducing new knowledge in this field.
It is possible that, for diseases such as leukemia, the
day when classical epidemiology will give its place to en-
vironmental genomics or proteomics to investigate com-
plex interactions between occupational or environmental
exposures and their effect at genetic or molecular level,
is not far from today.
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